Association of high risk of liver fibrosis in patients with serious outcomes of adverse drug reactions
{{output}}
Purpose: Metabolic dysfunction–associated steatotic liver disease (MASLD) as the main cause of chronic liver disease worldwide is associated with increased mortality. Especially in patients with fibrosis, an increased risk of ad... ...
